Used in the development of therapies targeting inflammatory diseases by blocking the interaction between VCAM-1 and integrins, thereby reducing leukocyte adhesion and migration into tissues. This antibody is particularly valuable in research and treatment strategies for conditions such as atherosclerosis, rheumatoid arthritis, and multiple sclerosis. It serves as a reference in bioassays for evaluating the efficacy of anti-inflammatory biologics and supports the development of biosimilars. Its high specificity makes it suitable for diagnostic applications and in vivo imaging of vascular inflammation.